Evidence map›Paper›PMID 39762237›Full record

ArticleHuman genome variation2025

A novel UBA1 gene mutation in a patient with infantile respiratory distress syndrome.

Masafumi Miyata, Arisa Kojima, Yuri Kawai, Hidetoshi Uchida, Hiroko Boda, Naoko Ishihara, Hidehito Inagaki, Tetsushi Yoshikawa, Hiroki Kurahashi

Abstract read
In one paragraph

Article in Human genome variation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Masafumi MiyataDepartment of Pediatrics, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Arisa KojimaDepartment of Pediatrics, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Yuri KawaiDepartment of Pediatrics, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Hidetoshi UchidaDepartment of Pediatrics, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Hiroko BodaDepartment of Pediatrics, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Naoko IshiharaDepartment of Pediatrics, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Hidehito InagakiDivision of Molecular Genetics, Center for Medical Science, Fujita Health University Hospital, Toyoake, Aichi, Japan.ORCID http://orcid.org/0000-0002-2383-0619
Tetsushi YoshikawaDepartment of Pediatrics, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Hiroki KurahashiDivision of Molecular Genetics, Center for Medical Science, Fujita Health University Hospital, Toyoake, Aichi, Japan. kura@fujita-hu.ac.jp.ORCID http://orcid.org/0000-0002-5690-5218

Funding

Japan Agency for Medical Research and Development (AMED) 18ek0109301s2201
6 · The paper itself

Abstract

UBA1 is an E1 ubiquitin-activating enzyme that initiates the ubiquitylation of target proteins and is thus a key component of the ubiquitin signaling pathway. Three disorders are associated with pathogenic variants of the UBA1 gene: vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome, lung cancer in never smokers (LCINS), and X-linked spinal muscular atrophy (XL-SMA, SMAX2). We here report a case of infantile respiratory distress syndrome followed by continuing neuromuscular symptoms. We identified a de novo hemizygous mutation, c.1660 C > T (p.Pro554Ser), in exon 15 of the UBA1 gene in this baby. This missense mutation was located with the AAD (active adenylation domain) of the protein, a known hotspot of SMAX2 mutations. This case lends support to the genotype-phenotype correlation regarding the UBA1 mutation and its related diseases.

Identifiers

PMID39762237
PMCPMC11704066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.